Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Kilitch Drugs(I) Ltd.

Feb 13 BSE 329.60 ( -2.15 -0.65%)

Volume1513

Prev. Close
331.75

Open Price
329.00

Today's Low / High

325.55 339.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

278.16 490.00

Feb 13 NSE 326.95( -3.05 -0.92%)

Volume17391

Prev. Close
330.00

Open Price
330.00

Today's Low / High

325.15 337.05

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

304.51 500.00

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	197.24	153.61	138.86	112.96	68.13
Other Operating Revenues	1.08	0.77	0.74	1.28	0.39
Total Operating Revenues	198.32	154.37	139.60	114.23	68.52

Other Income	11.16	4.48	2.92	2.91	2.67
Total Revenue	209.48	158.85	142.52	117.14	71.19

EXPENSES
Cost Of Materials Consumed	105.75	79.08	74.53	65.48	36.22
Changes In Inventories Of FG,WIP And Stock-In Trade	-1.17	-0.12	0.23	-0.05	1.09
Employee Benefit Expenses	11.32	10.01	11.73	6.18	5.24
Finance Costs	5.04	5.93	4.92	1.20	0.75
Depreciation And Amortisation Expenses	3.11	3.35	3.55	2.47	1.99
Other Expenses	50.95	41.24	35.54	32.25	20.78
Total Expenses	175.00	139.50	130.50	107.53	66.07

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.47	19.35	12.01	9.61	5.12

Profit/Loss Before Tax	34.47	19.35	12.01	9.61	5.12

Tax Expenses-Continued Operations
Current Tax	9.85	6.37	4.20	3.63	1.67
Deferred Tax	-0.32	-0.59	-0.47	-0.23	-0.31
Total Tax Expenses	9.53	5.78	3.73	3.40	1.35
Profit/Loss After Tax And Before ExtraOrdinary Items	24.94	13.58	8.28	6.21	3.77

Profit/Loss From Continuing Operations	24.94	13.58	8.28	6.21	3.77

Profit/Loss For The Period	24.94	13.58	8.28	6.21	3.77

Minority Interest	1.76	1.03	2.17	1.15	-0.10
Consolidated Profit/Loss After MI And Associates	26.70	14.60	10.45	7.37	3.67

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	16.60	9.17	6.71	4.73	2.37
Diluted EPS (Rs.)	16.60	9.17	6.71	4.73	2.37

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	197.24
Other Operating Revenues	1.08
Total Operating Revenues	198.32
Other Income	11.16
Total Revenue	209.48
EXPENSES
Cost Of Materials Consumed	105.75
Changes In Inventories Of FG,WIP And Stock-In Trade	-1.17
Employee Benefit Expenses	11.32
Finance Costs	5.04
Depreciation And Amortisation Expenses	3.11
Other Expenses	50.95
Total Expenses	175.00
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	34.47
Profit/Loss Before Tax	34.47
Tax Expenses-Continued Operations
Current Tax	9.85
Deferred Tax	-0.32
Total Tax Expenses	9.53
Profit/Loss After Tax And Before ExtraOrdinary Items	24.94
Profit/Loss From Continuing Operations	24.94
Profit/Loss For The Period	24.94
Minority Interest	1.76
Consolidated Profit/Loss After MI And Associates	26.70
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	16.60
Diluted EPS (Rs.)	16.60